310 related articles for article (PubMed ID: 26654772)
21. Polycystic Ovary Syndrome Pathophysiology: Integrating Systemic, CNS and Circadian Processes.
Anderson G
Front Biosci (Landmark Ed); 2024 Jan; 29(1):24. PubMed ID: 38287831
[TBL] [Abstract][Full Text] [Related]
22. Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report.
Reininghaus EZ; McIntyre RS; Reininghaus B; Geisler S; Bengesser SA; Lackner N; Hecht K; Birner A; Kattnig F; Unterweger R; Kapfhammer HP; Zelzer S; Fuchs D; Mangge H
Bipolar Disord; 2014 Jun; 16(4):432-40. PubMed ID: 24330408
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis.
Hebbrecht K; Skorobogatov K; Giltay EJ; Coppens V; De Picker L; Morrens M
Front Immunol; 2021; 12():667179. PubMed ID: 34093561
[TBL] [Abstract][Full Text] [Related]
24. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
Anderson G; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():5-19. PubMed ID: 22800757
[TBL] [Abstract][Full Text] [Related]
25. Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer.
Barreto FS; Chaves Filho AJM; de Araújo MCCR; de Moraes MO; de Moraes MEA; Maes M; de Lucena DF; Macedo DS
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):165-180. PubMed ID: 29543650
[TBL] [Abstract][Full Text] [Related]
26. [Kynurenine pathway in bipolar disorder].
Konstantinou G; Papageorgiou CC; Angelopoulos E
Psychiatriki; 2018; 29(4):338-348. PubMed ID: 30814043
[TBL] [Abstract][Full Text] [Related]
27. Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways.
Anderson G; Maes M; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():101-14. PubMed ID: 22930036
[TBL] [Abstract][Full Text] [Related]
28. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
Oxenkrug GF
Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
[TBL] [Abstract][Full Text] [Related]
29. Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization.
Anderson G; Maes M; Berk M
Adv Protein Chem Struct Biol; 2012; 88():27-48. PubMed ID: 22814705
[TBL] [Abstract][Full Text] [Related]
30. Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.
Anderson G; Berk M; Dean O; Moylan S; Maes M
CNS Drugs; 2014 Jan; 28(1):1-10. PubMed ID: 24150993
[TBL] [Abstract][Full Text] [Related]
31. How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications.
Anderson G; Maes M
CNS Neurol Disord Drug Targets; 2017; 16(3):266-278. PubMed ID: 27875954
[TBL] [Abstract][Full Text] [Related]
32. Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism.
Songtachalert T; Roomruangwong C; Carvalho AF; Bourin M; Maes M
Curr Top Med Chem; 2018; 18(19):1704-1715. PubMed ID: 30430940
[TBL] [Abstract][Full Text] [Related]
33. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
[TBL] [Abstract][Full Text] [Related]
34. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
[TBL] [Abstract][Full Text] [Related]
35. Breastfeeding and the gut-brain axis: is there a role for melatonin?
Anderson G; Vaillancourt C; Maes M; Reiter RJ
Biomol Concepts; 2017 Sep; 8(3-4):185-195. PubMed ID: 28723608
[TBL] [Abstract][Full Text] [Related]
36. Tryptophan Metabolism in Bipolar Disorder in a Longitudinal Setting.
Fellendorf FT; Gostner JM; Lenger M; Platzer M; Birner A; Maget A; Queissner R; Tmava-Berisha A; Pater CA; Ratzenhofer M; Wagner-Skacel J; Bengesser SA; Dalkner N; Fuchs D; Reininghaus EZ
Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829665
[TBL] [Abstract][Full Text] [Related]
37. Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression.
Anderson G; Kubera M; Duda W; Lasoń W; Berk M; Maes M
Pharmacol Rep; 2013; 65(6):1647-54. PubMed ID: 24553013
[TBL] [Abstract][Full Text] [Related]
38. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells.
Anderson G; Rodriguez M; Reiter RJ
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694154
[TBL] [Abstract][Full Text] [Related]
39. A More Holistic Perspective of Alzheimer's Disease: Roles of Gut Microbiome, Adipocytes, HPA Axis, Melatonergic Pathway and Astrocyte Mitochondria in the Emergence of Autoimmunity.
Anderson G
Front Biosci (Landmark Ed); 2023 Dec; 28(12):355. PubMed ID: 38179773
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer: Occluded role of mitochondria N-acetylserotonin/melatonin ratio in co-ordinating pathophysiology.
Anderson G
Biochem Pharmacol; 2019 Oct; 168():259-268. PubMed ID: 31310736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
